12/13
07:50 am
phat
Phathom Pharmaceuticals (NASDAQ:PHAT) was upgraded by analysts at Raymond James Financial, Inc. to a "strong-buy" rating.
Low
Report
Phathom Pharmaceuticals (NASDAQ:PHAT) was upgraded by analysts at Raymond James Financial, Inc. to a "strong-buy" rating.
12/11
05:04 pm
phat
Phathom Pharmaceuticals (NASDAQ:PHAT) is now covered by analysts at Raymond James Financial, Inc.. They set a "strong-buy" rating on the stock.
Low
Report
Phathom Pharmaceuticals (NASDAQ:PHAT) is now covered by analysts at Raymond James Financial, Inc.. They set a "strong-buy" rating on the stock.
12/11
04:10 pm
phat
Phathom Pharmaceuticals initiated with a Strong Buy at Raymond James
Low
Report
Phathom Pharmaceuticals initiated with a Strong Buy at Raymond James
12/11
04:10 pm
phat
Phathom Pharmaceuticals initiated with a Strong Buy at Raymond James
Low
Report
Phathom Pharmaceuticals initiated with a Strong Buy at Raymond James
12/11
06:29 am
phat
Phathom Pharmaceuticals (NASDAQ:PHAT) was upgraded by analysts at Barclays PLC to a "hold" rating.
Low
Report
Phathom Pharmaceuticals (NASDAQ:PHAT) was upgraded by analysts at Barclays PLC to a "hold" rating.
12/9
11:05 am
phat
Rating for PHAT
Low
Report
Rating for PHAT
12/9
11:05 am
phat
Rating for PHAT
Low
Report
Rating for PHAT
12/8
04:27 pm
phat
Phathom Pharmaceuticals initiated with an Equal Weight at Barclays
Medium
Report
Phathom Pharmaceuticals initiated with an Equal Weight at Barclays
12/8
04:27 pm
phat
Phathom Pharmaceuticals initiated with an Equal Weight at Barclays
Medium
Report
Phathom Pharmaceuticals initiated with an Equal Weight at Barclays
10/31
10:07 am
phat
Phathom Pharmaceuticals (NASDAQ:PHAT) had its "buy" rating reaffirmed by analysts at Craig Hallum.
Low
Report
Phathom Pharmaceuticals (NASDAQ:PHAT) had its "buy" rating reaffirmed by analysts at Craig Hallum.
10/31
10:07 am
phat
Phathom Pharmaceuticals (NASDAQ:PHAT) had its "buy" rating reaffirmed by analysts at Craig Hallum.
Low
Report
Phathom Pharmaceuticals (NASDAQ:PHAT) had its "buy" rating reaffirmed by analysts at Craig Hallum.
10/31
07:19 am
phat
Phathom Pharmaceuticals (NASDAQ:PHAT) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Low
Report
Phathom Pharmaceuticals (NASDAQ:PHAT) had its "buy" rating reaffirmed by analysts at HC Wainwright.
10/30
06:06 pm
phat
Phathom Pharmaceuticals (NASDAQ:PHAT) had its "buy" rating reaffirmed by analysts at Guggenheim.
Low
Report
Phathom Pharmaceuticals (NASDAQ:PHAT) had its "buy" rating reaffirmed by analysts at Guggenheim.
10/30
06:06 pm
phat
Phathom Pharmaceuticals (NASDAQ:PHAT) had its "buy" rating reaffirmed by analysts at Guggenheim.
Low
Report
Phathom Pharmaceuticals (NASDAQ:PHAT) had its "buy" rating reaffirmed by analysts at Guggenheim.